150 related articles for article (PubMed ID: 38258341)
1. Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer.
Fang K; Wang J; Yuan J; Sui C; Zhi J; Xia Y; Sun M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1952. PubMed ID: 38258341
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Adequate Management for Complications of Bevacizumab Treatment Requiring Surgical Intervention in Patients With Metastatic Colorectal Cancer.
Bong JW; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim TW; Kim JC
Clin Colorectal Cancer; 2018 Dec; 17(4):e639-e645. PubMed ID: 30031634
[TBL] [Abstract][Full Text] [Related]
4. Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents.
Pacheco-Barcia V; Mondéjar R; Martínez-Sáez O; Longo F; Moreno JA; Rogado J; Donnay O; Santander C; Carrato A; Colomer R
Clin Colorectal Cancer; 2019 Sep; 18(3):e287-e293. PubMed ID: 31262698
[TBL] [Abstract][Full Text] [Related]
5. Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review.
Imbulgoda A; MacLean A; Heine J; Drolet S; Vickers MM
Can J Surg; 2015 Jun; 58(3):167-71. PubMed ID: 25799132
[TBL] [Abstract][Full Text] [Related]
6. The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study.
Sfakianos GP; Numnum TM; Halverson CB; Panjeti D; Kendrick JE; Straughn JM
Gynecol Oncol; 2009 Sep; 114(3):424-6. PubMed ID: 19552944
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal perforation due to bevacizumab in colorectal cancer.
Saif MW; Elfiky A; Salem RR
Ann Surg Oncol; 2007 Jun; 14(6):1860-9. PubMed ID: 17356952
[TBL] [Abstract][Full Text] [Related]
8. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Surgery; 2000 Apr; 127(4):370-6. PubMed ID: 10776426
[TBL] [Abstract][Full Text] [Related]
9. Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated.
Borzomati D; Nappo G; Valeri S; Vincenzi B; Ripetti V; Coppola R
Updates Surg; 2013 Jun; 65(2):121-4. PubMed ID: 23532741
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients.
Saito S; Hayashi N; Sato N; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Watanabe M; Yoshida M; Sakai K; Katsumori T; Katahuchi S; Shigaki N; Yamada K; Kimura M; Tanigawa T; Takano S; Kuramoto M; Baba H
Int J Clin Oncol; 2013 Aug; 18(4):689-95. PubMed ID: 22664951
[TBL] [Abstract][Full Text] [Related]
11. Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer.
Qureshi S; Elliott RB; Herrington JD
J Oncol Pharm Pract; 2017 Dec; 23(8):625-628. PubMed ID: 27604142
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients.
Borofsky SE; Levine MS; Rubesin SE; Tanyi JL; Chu CS; Lev-Toaff AS
Abdom Imaging; 2013 Apr; 38(2):265-72. PubMed ID: 22627832
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab-related gastrointestinal perforation in patients with three or more prior chemotherapy regimens: A real-world experience.
Matsumiya H; Todo Y; Yamazaki H; Shimada C; Minobe S; Kato H
Taiwan J Obstet Gynecol; 2020 May; 59(3):377-380. PubMed ID: 32416883
[TBL] [Abstract][Full Text] [Related]
14. Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab.
Liu SV; Gollard R; Iqbal S
J Clin Pharm Ther; 2012 Oct; 37(5):607-9. PubMed ID: 22432770
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
Kabbinavar FF; Flynn PJ; Kozloff M; Ashby MA; Sing A; Barr CE; Grothey A
Eur J Cancer; 2012 May; 48(8):1126-32. PubMed ID: 22424880
[TBL] [Abstract][Full Text] [Related]
16. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
17. [Four Cases of Gastrointestinal Perforation Associated with Bevacizumab].
Uemura K; Takahashi H; Mino K; Ota T; Shichi S
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1604-1606. PubMed ID: 29394716
[TBL] [Abstract][Full Text] [Related]
18. [Four cases of bevacizumab-related gastrointestinal perforation].
Uchino T; Mishima H; Kimura K; Mori D; Ando K; Nagata H; Kondo R; Kosaka K; Ohashi N; Ito N; Arikawa T; Miyachi M; Suzumura K; Sano T; Nonami T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2506-8. PubMed ID: 25731572
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
[TBL] [Abstract][Full Text] [Related]
20. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]